{"id":"multiple-daily-injections-of-insulin","safety":{"commonSideEffects":[{"rate":"variable, dose-dependent","effect":"Hypoglycemia"},{"rate":"common","effect":"Weight gain"},{"rate":"5-10","effect":"Injection site reactions"},{"rate":"variable","effect":"Lipodystrophy"}]},"_chembl":{"chemblId":"CHEMBL2108490","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Insulin is a hormone that facilitates glucose uptake into cells and promotes glycogen synthesis, lowering blood glucose. Multiple daily injection (MDI) regimens typically combine long-acting basal insulin with rapid-acting bolus insulin at meals to mimic physiological insulin secretion patterns. This approach allows flexible dosing and meal-time coverage for improved glycemic control in diabetes.","oneSentence":"Multiple daily insulin injections replace or supplement the body's own insulin production to regulate blood glucose levels.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:56:11.732Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 1 diabetes mellitus"},{"name":"Type 2 diabetes mellitus (when oral agents are insufficient)"}]},"trialDetails":[{"nctId":"NCT07423637","phase":"NA","title":"The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Control and Comorbidities, and Cost-effectiveness of AID Treatment","status":"NOT_YET_RECRUITING","sponsor":"Helsinki University Central Hospital","startDate":"2026-04-01","conditions":"Type 1 Diabetes","enrollment":100},{"nctId":"NCT06198725","phase":"NA","title":"Intervention for Children With Type 1 Diabetes Targeting Gut Microbes","status":"RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2024-01-08","conditions":"Type 1 Diabetes","enrollment":110},{"nctId":"NCT05985135","phase":"NA","title":"Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-06-01","conditions":"Type 1 Diabetes","enrollment":70},{"nctId":"NCT05653518","phase":"NA","title":"Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2023-09-09","conditions":"Type 1 Diabetes","enrollment":40},{"nctId":"NCT06449677","phase":"PHASE3","title":"Bionic Pancreas in CFRD","status":"RECRUITING","sponsor":"Jaeb Center for Health Research","startDate":"2024-09-24","conditions":"Cystic Fibrosis-related Diabetes","enrollment":150},{"nctId":"NCT06111586","phase":"PHASE2","title":"FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)","status":"RECRUITING","sponsor":"Sanofi","startDate":"2023-12-11","conditions":"Type 1 Diabetes Mellitus","enrollment":192},{"nctId":"NCT07287943","phase":"NA","title":"To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.","status":"RECRUITING","sponsor":"Viral N. Shah","startDate":"2026-02-09","conditions":"Type 1 Diabetes, Gastroparesis Due to Diabetes Mellitus Type I","enrollment":34},{"nctId":"NCT06330194","phase":"NA","title":"Next Generation Advanced Insulin Delivery System in Adults With Diabetes and Advanced Renal Disease","status":"COMPLETED","sponsor":"Steno Diabetes Center Copenhagen","startDate":"2024-04-18","conditions":"Dialysis, Chronic Kidney Disease, Diabetes Mellitus, Type 2","enrollment":15},{"nctId":"NCT05669547","phase":"NA","title":"Dual Hormone Closed Loop in Type 1 Diabetes","status":"COMPLETED","sponsor":"UMC Utrecht","startDate":"2023-10-03","conditions":"Diabetes Mellitus, Type 1, Diabetes type1, Diabetes","enrollment":243},{"nctId":"NCT06236607","phase":"NA","title":"Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes","status":"RECRUITING","sponsor":"Boston Medical Center","startDate":"2025-02-27","conditions":"Diabetes Mellitus, Type 1, Diabetes Complications","enrollment":140},{"nctId":"NCT07241702","phase":"","title":"EFFECT OF HYBRID CLOSED-LOOP SYSTEMS ON CARDIOVASCULAR MARKERS IN TYPE 1 DIABETES.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Attikon Hospital","startDate":"2019-09-01","conditions":"Type 1 Diabetes","enrollment":100},{"nctId":"NCT06418880","phase":"PHASE3","title":"Automated Insulin Delivery for Inpatients With Dysglycemia","status":"COMPLETED","sponsor":"Emory University","startDate":"2025-01-22","conditions":"Type 1 Diabetes, Type 2 Diabetes","enrollment":130},{"nctId":"NCT04443153","phase":"NA","title":"Adapting Diabetes Treatment Expert Systems to Patient in Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2020-09-04","conditions":"Diabetes Mellitus, Type 1","enrollment":88},{"nctId":"NCT06411548","phase":"NA","title":"InsuLearn Feasibility With Type 1 Diabetes Patients Under MDI Therapy","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2025-03-27","conditions":"Type 1 Diabetes Mellitus","enrollment":7},{"nctId":"NCT06529705","phase":"NA","title":"Performance and Safety Evaluation of the EkiYou V2 Application in Patients With Diabetes Using Multiple Daily Insulin Injections (EkiYou-Study1)","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2024-08-19","conditions":"Diabetes Type 1, Diabetes Type 2 on Insulin, Pancreatogenous Diabetes","enrollment":21},{"nctId":"NCT05463744","phase":"PHASE3","title":"A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2022-08-12","conditions":"Type 1 Diabetes, Diabetes","enrollment":692},{"nctId":"NCT05065372","phase":"PHASE1","title":"MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes","status":"RECRUITING","sponsor":"Kalie Tommerdahl","startDate":"2022-07-01","conditions":"Type 1 Diabetes, Diabetic Kidney Disease, Cardiovascular Diseases","enrollment":60},{"nctId":"NCT06985095","phase":"NA","title":"Evaluation of a Structured Nutrition Educational Program in Insulin-treated Diabetic Patients in Vietnam","status":"RECRUITING","sponsor":"Cho Ray Hospital","startDate":"2025-04-04","conditions":"Diabetes Mellitus","enrollment":115},{"nctId":"NCT05462756","phase":"PHASE3","title":"A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2022-08-11","conditions":"Type 2 Diabetes, Type 2 Diabetes Treated With Insulin","enrollment":730},{"nctId":"NCT04233229","phase":"NA","title":"Evaluation of a Closed-loop Insulin Delivery System at Home With Tailored Home Care Services in Poorly Controlled Type 2 Diabetes Patients (T2D)","status":"COMPLETED","sponsor":"Air Liquide Santé International","startDate":"2019-12-30","conditions":"Diabetes Type 2","enrollment":43},{"nctId":"NCT04617795","phase":"NA","title":"Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes","status":"COMPLETED","sponsor":"Insulet Corporation","startDate":"2020-11-23","conditions":"Type 2 Diabetes Mellitus","enrollment":25},{"nctId":"NCT06283797","phase":"NA","title":"Efficacy of Automated Insulin Therapy Early Initiated After Diagnosis on Blood Glucose Control in Children and Adolescents With Type 1 Diabetes","status":"RECRUITING","sponsor":"University Hospital, Montpellier","startDate":"2024-05-29","conditions":"Diabetes","enrollment":112},{"nctId":"NCT03945747","phase":"","title":"MEtabolic and Renal Effects of AutoMAted Insulin Delivery Systems in Youth With Type 1 Diabetes Mellitus","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2019-08-14","conditions":"Type1 Diabetes Mellitus, Diabetes Mellitus, Type 1, Autoimmune Diabetes","enrollment":50},{"nctId":"NCT06855615","phase":"PHASE4","title":"Comparison of Thrice-Daily Premixed Human Insulin with Basal-Bolus Therapy Among Patients with Poorly Controlled Type 2 Diabetes Mellitus","status":"COMPLETED","sponsor":"Hospital Sultanah Aminah Johor Bahru","startDate":"2020-10-01","conditions":"Type 2 Diabetes Mellitus (T2DM)","enrollment":44},{"nctId":"NCT04538352","phase":"PHASE4","title":"Transition From Basal/Bolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2021-01-18","conditions":"Type 2 Diabetes","enrollment":60},{"nctId":"NCT01073566","phase":"PHASE2","title":"Feasibility Study of Finesse for Bolus Prandial Insulin Dosing Compared to Multiple Daily Injections","status":"COMPLETED","sponsor":"Calibra Medical, Inc.","startDate":"2010-01","conditions":"Diabetes Mellitus","enrollment":38},{"nctId":"NCT06577584","phase":"","title":"Comparison of Diabetes Patients - Care Trajectory Versus Convention","status":"NOT_YET_RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2025-02-01","conditions":"Type 2 Diabetes","enrollment":20000},{"nctId":"NCT04809285","phase":"NA","title":"Use of the Guardian™ Connect System With Smart Connected Devices","status":"COMPLETED","sponsor":"Medtronic Diabetes","startDate":"2021-04-06","conditions":"Type 1 Diabetes Mellitus","enrollment":217},{"nctId":"NCT04520971","phase":"NA","title":"Closed-loop Insulin Delivery in Pregnant Women With Type 1 Diabetes","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2021-01-15","conditions":"Type1 Diabetes","enrollment":95},{"nctId":"NCT05159453","phase":"PHASE2, PHASE3","title":"Dose Response Study of Transdermal Human Insulin in Patients","status":"NOT_YET_RECRUITING","sponsor":"Transdermal Delivery Solutions Corp","startDate":"2025-09-02","conditions":"Glucose, High Blood","enrollment":30},{"nctId":"NCT02897219","phase":"PHASE3","title":"A Study of ASP1941 in Combination With Insulin in Patients With Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"Astellas Pharma Inc","startDate":"2016-08-29","conditions":"Type 1 Diabetes Mellitus","enrollment":175},{"nctId":"NCT06311019","phase":"NA","title":"The Effects of CGM and Connected Pen in T2DM Treated With Multiple Daily Insulin Injections","status":"ACTIVE_NOT_RECRUITING","sponsor":"Klavs Würgler Hansen","startDate":"2024-02-27","conditions":"Type 2 Diabetes Treated With Insulin","enrollment":104},{"nctId":"NCT05923827","phase":"NA","title":"Omnipod® 5 With Libre 2 vs. MDI for Type 1 Diabetes in Children and Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"Insulet Corporation","startDate":"2023-09-11","conditions":"Diabetes Mellitus, Type 1","enrollment":200},{"nctId":"NCT04270656","phase":"NA","title":"Liver and Metabolic Effects of Insulin Pump Therapy in Diabetics Type 2 with Non-alcoholic Hepatic Steatosis","status":"COMPLETED","sponsor":"Nantes University Hospital","startDate":"2021-02-05","conditions":"Type 2 Diabetes (T2D)","enrollment":46},{"nctId":"NCT05118945","phase":"","title":"Study on the Use of the Insulin Pump Tandem X:2 With Control IQ Algorithm - Update","status":"COMPLETED","sponsor":"Kinderkrankenhaus auf der Bult","startDate":"2021-03-03","conditions":"Type 1 Diabetes, Insulin Therapy","enrollment":50},{"nctId":"NCT06556641","phase":"PHASE1","title":"A Clinical Study of GZR33 and GZR101 in Healthy Subjects","status":"COMPLETED","sponsor":"Gan and Lee Pharmaceuticals, USA","startDate":"2022-12-17","conditions":"Healthy Subjects","enrollment":28},{"nctId":"NCT05904743","phase":"PHASE4","title":"INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes","status":"COMPLETED","sponsor":"Mannkind Corporation","startDate":"2023-07-07","conditions":"Diabetes Mellitus, Type 1","enrollment":141},{"nctId":"NCT02558491","phase":"NA","title":"Feasibility of a Decision Support System to Reduce Glucose Variability in Subject With T1DM","status":"COMPLETED","sponsor":"Daniel Chernavvsky, MD","startDate":"2015-09","conditions":"Type 1 Diabetes Mellitus","enrollment":33},{"nctId":"NCT01076218","phase":"","title":"Navigator 1.5 Accuracy Study","status":"COMPLETED","sponsor":"Abbott Diabetes Care","startDate":"2008-04","conditions":"Diabetes Mellitus","enrollment":57},{"nctId":"NCT04926623","phase":"NA","title":"Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2)","status":"COMPLETED","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2021-06-17","conditions":"Type 2 Diabetes Mellitus","enrollment":159},{"nctId":"NCT06418464","phase":"NA","title":"Efficacy and Safety of an Artificial-pancreas-like Learning-based Control in Type 1 Diabetes on Multiple Daily Injection Therapy","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2024-07-01","conditions":"Diabetes Mellitus, Type 1","enrollment":120},{"nctId":"NCT02871089","phase":"NA","title":"Closed Loop From Onset in Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cambridge","startDate":"2017-01","conditions":"Diabetes Mellitus, Type 1 Diabetes","enrollment":96},{"nctId":"NCT04123054","phase":"NA","title":"A Novel mHealth Application Guided by an Optimization Algorithm for T1D Sensor-Augmented Insulin Injection Users","status":"COMPLETED","sponsor":"McGill University","startDate":"2020-03-05","conditions":"Diabetes Mellitus, Diabetes Mellitus, Type 1","enrollment":84},{"nctId":"NCT06408532","phase":"PHASE4","title":"The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2024-04-30","conditions":"Diabetes Mellitus, Type 2","enrollment":256},{"nctId":"NCT05628532","phase":"NA","title":"DBLG1 System With TERUMO MEDISAFE WITH Insulin Pump Trial","status":"COMPLETED","sponsor":"Diabeloop","startDate":"2023-02-03","conditions":"Diabetes Mellitus, Type 1","enrollment":90},{"nctId":"NCT06071325","phase":"","title":"Green Digital Diabetes Waste Project","status":"COMPLETED","sponsor":"Florida State University","startDate":"2023-09-19","conditions":"Diabetes Mellitus, Diabetes Mellitus, Type 2, Diabetes Mellitus, Type 1","enrollment":49},{"nctId":"NCT06347783","phase":"","title":"Automated Insulin Delivery vs. Injections: Sleep Impact in Pediatric Type 1 Diabetes","status":"NOT_YET_RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2024-05-15","conditions":"Type1diabetes","enrollment":80},{"nctId":"NCT04653961","phase":"NA","title":"Evaluation of a Decision Support System for People With Diabetes Who Use Multiple Daily Insulin Injections- Feasibility and Proof of Concept Studies","status":"RECRUITING","sponsor":"Rabin Medical Center","startDate":"2020-06-01","conditions":"Type1diabetes","enrollment":48},{"nctId":"NCT03429543","phase":"PHASE3","title":"Diabetes Study of Linagliptin and Empagliflozin in Children and Adolescents (DINAMO)TM","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2018-03-20","conditions":"Diabetes Mellitus, Type 2","enrollment":175},{"nctId":"NCT06236256","phase":"NA","title":"Advanced Hybrid Closed Loop System (AHCL) in Older Patients With Type 1 Diabetes Mellitus","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2024-01-09","conditions":"Diabetes Mellitus, Type 1","enrollment":40},{"nctId":"NCT06207838","phase":"NA","title":"Transition of T1DM Patients Aged Over 65 Years Into AHCL (780G) Insulin Pump","status":"UNKNOWN","sponsor":"Jagiellonian University","startDate":"2023-09-14","conditions":"Diabetes Type 1","enrollment":30},{"nctId":"NCT04575181","phase":"PHASE1","title":"A Clinical Study to Compare the Efficacy and Safety of a Novel Medicine (NNC0268-0965) With Insulin Glargine","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2020-10-21","conditions":"Diabetes Mellitus, Type 2","enrollment":86},{"nctId":"NCT05029271","phase":"NA","title":"InPen User Experience","status":"COMPLETED","sponsor":"Medtronic Diabetes","startDate":"2023-04-17","conditions":"Diabetes Type 1","enrollment":34},{"nctId":"NCT02491528","phase":"PHASE3","title":"A Phase III Study of Insulin Aspart Injection to Evaluate the Efficacy and Safety","status":"COMPLETED","sponsor":"Tonghua Dongbao Pharmaceutical Co.,Ltd","startDate":"2015-06-19","conditions":"Diabetes","enrollment":563},{"nctId":"NCT03676465","phase":"NA","title":"CloudConnect: Predictive And Retrospective Clinical Decision Support For Chronic Disease Management","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2019-01-18","conditions":"Type 1 Diabetes Mellitus","enrollment":132},{"nctId":"NCT04938557","phase":"NA","title":"Automated Insulin Delivery Amongst Pregnant Women With Type 1 Diabetes","status":"COMPLETED","sponsor":"Norfolk and Norwich University Hospitals NHS Foundation Trust","startDate":"2019-09-26","conditions":"Diabetes","enrollment":124},{"nctId":"NCT03660553","phase":"PHASE4","title":"Simplified Insulin Regimen for the Elderly","status":"TERMINATED","sponsor":"University of Miami","startDate":"2018-10-10","conditions":"Type 2 Diabetes Mellitus","enrollment":7},{"nctId":"NCT06141629","phase":"NA","title":"Benefits of a Bolus Calculator in Pediatric Patients on Multiple Daily Insulin Injections","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2015-01","conditions":"Poor Glycemic Control, Quality of Life","enrollment":30},{"nctId":"NCT00913497","phase":"PHASE4","title":"The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children","status":"COMPLETED","sponsor":"Corewell Health West","startDate":"2009-06","conditions":"Type 1 Diabetes Mellitus","enrollment":16},{"nctId":"NCT05733962","phase":"NA","title":"Evaluation of the Efficacy and Safety of DBL-4pen Mobile Application in Patients With Type 2 Diabetes","status":"UNKNOWN","sponsor":"Diabeloop","startDate":"2024-01","conditions":"Diabetes Mellitus, Type 2","enrollment":40},{"nctId":"NCT05969106","phase":"","title":"Tandem Control-IQ Evaluation Regarding Glucose Metrics, Sleep, and Health Economics","status":"COMPLETED","sponsor":"Vastra Gotaland Region","startDate":"2020-01-01","conditions":"Type 1 Diabetes","enrollment":84},{"nctId":"NCT00357890","phase":"NA","title":"Insulin Pump Therapy in Adolescents With Newly Diagnosed Type 1 Diabetes (T1D)","status":"COMPLETED","sponsor":"Nemours Children's Clinic","startDate":"2005-12","conditions":"Diabetes Mellitus, Insulin-Dependent","enrollment":12},{"nctId":"NCT04796779","phase":"NA","title":"The Pediatric Artificial Pancreas (PEDAP) Trial of Control-IQ Technology in Young Children in Type 1 Diabetes","status":"COMPLETED","sponsor":"Marc Breton","startDate":"2021-04-21","conditions":"Type 1 Diabetes","enrollment":102},{"nctId":"NCT00858273","phase":"NA","title":"Glutathione Metabolism in Adolescents With Type 1 Diabetes - Study B","status":"COMPLETED","sponsor":"Nemours Children's Clinic","startDate":"2008-03","conditions":"Diabetes Mellitus, Type 1","enrollment":41},{"nctId":"NCT03844789","phase":"NA","title":"A Study of t:Slim X2 With Control-IQ Technology","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2019-06-06","conditions":"Type 1 Diabetes Mellitus","enrollment":101},{"nctId":"NCT03093636","phase":"NA","title":"Efficacy of inControl Advice: A Decision Support System (DSS) for Diabetes","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2017-04-17","conditions":"Type1 Diabetes Mellitus","enrollment":80},{"nctId":"NCT03689374","phase":"PHASE3","title":"A Research Study to Compare Semaglutide to Insulin Aspart, When Taken Together With Metformin and Insulin Glargine, in People With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2018-10-01","conditions":"Diabetes Mellitus, Type 2","enrollment":2274},{"nctId":"NCT05134987","phase":"PHASE1","title":"A Multiple Dose Study Investigating Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0363-0845 in Participants With Type 1 Diabetes Pharmacokinetics and Pharmacodynamics: How Insulin NNC0363-0845 is Transported Throughout the Body and How It Works","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2021-12-01","conditions":"Diabetes Mellitus, Type 1","enrollment":30},{"nctId":"NCT03668808","phase":"PHASE4","title":"Comparison of Insulin Degludec With Insulin Glargine U100 for Adults With Type 1 Diabetes Crossing Multiple Time Zones.","status":"COMPLETED","sponsor":"Sansum Diabetes Research Institute","startDate":"2018-11-16","conditions":"Diabetes Mellitus, Type 1","enrollment":25},{"nctId":"NCT04450407","phase":"PHASE2","title":"A Study of LY3209590 in Participants With Type 1 Diabetes","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2020-07-06","conditions":"Type 1 Diabetes Mellitus","enrollment":266},{"nctId":"NCT05574023","phase":"NA","title":"Effect of CGM With Predictive Alarm on Hypoglycemia in Young Patients With T1D.","status":"COMPLETED","sponsor":"Azienda Ospedaliera Universitaria Integrata Verona","startDate":"2021-05-10","conditions":"Type 1 Diabetes","enrollment":20},{"nctId":"NCT04211220","phase":"NA","title":"Study to Assess the Metabolic Impact of IRTA© and Patients Satisfaction in Type 1 Diabetic Patients, Treated by Either Insulin Pump or Multiple Daily Insulin Injections, and Using Freestyle Libre®, a Real-time Continuous Glucose Monitoring","status":"COMPLETED","sponsor":"Rennes University Hospital","startDate":"2020-01-09","conditions":"Type 1 Diabetes","enrollment":64},{"nctId":"NCT03557151","phase":"NA","title":"Transdisciplinary Versus Usual Care for Type1 Diabetes in Adolescence","status":"COMPLETED","sponsor":"Nemours Children's Clinic","startDate":"2018-07-13","conditions":"Type 1 Diabetes Mellitus","enrollment":230},{"nctId":"NCT04871958","phase":"NA","title":"Individualized, Technological Interventions for Diabetes Care in the COVID-19 Ward","status":"TERMINATED","sponsor":"Federico II University","startDate":"2021-03-19","conditions":"Diabetes Mellitus, Covid19","enrollment":66},{"nctId":"NCT04816890","phase":"PHASE2","title":"A Trial to Assess the Efficacy and Safety of M1 Pram P037 Prandial Insulin in Subjects With Type 1 Diabetes (T1DM)","status":"COMPLETED","sponsor":"Adocia","startDate":"2021-03-23","conditions":"Type 1 Diabetes Mellitus","enrollment":80},{"nctId":"NCT04701424","phase":"NA","title":"Closed-loop in Adults With T2D Not Requiring Dialysis","status":"COMPLETED","sponsor":"University of Cambridge","startDate":"2020-12-16","conditions":"Type 2 Diabetes","enrollment":30},{"nctId":"NCT04025775","phase":"NA","title":"Closed-loop in Adults With T2D Requiring Dialysis","status":"COMPLETED","sponsor":"University of Cambridge","startDate":"2019-08-01","conditions":"Type 2 Diabetes, End Stage Renal Disease","enrollment":27},{"nctId":"NCT03359837","phase":"PHASE4","title":"Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-01-20","conditions":"Type 2 Diabetes Mellitus","enrollment":384},{"nctId":"NCT02194595","phase":"PHASE3","title":"Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)","status":"COMPLETED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2014-09","conditions":"Type 2 Diabetes","enrollment":105},{"nctId":"NCT03434119","phase":"PHASE3","title":"Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents","status":"TERMINATED","sponsor":"Sanofi","startDate":"2018-02-20","conditions":"Type 2 Diabetes Mellitus","enrollment":241},{"nctId":"NCT04783376","phase":"PHASE4","title":"Effect of Splitting Mealtime Insulin Doses After Mixed Meals High in Fat and Protein","status":"COMPLETED","sponsor":"Sohag University","startDate":"2021-04-12","conditions":"Type 1 Diabetes Mellitus","enrollment":43},{"nctId":"NCT05201846","phase":"NA","title":"Comparison of CSII and MDI in Pediatric Patients With Type 1 Diabetes","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2022-01-18","conditions":"Type 1 Diabetes","enrollment":66},{"nctId":"NCT04283318","phase":"NA","title":"Prolonged Fasting on Glucose Metabolism and Hormonal Regulation in Healthy, Obese and Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Medical University of Graz","startDate":"2018-06-13","conditions":"Healthy, Obesity, Type 2 Diabetes Mellitus","enrollment":80},{"nctId":"NCT03143816","phase":"PHASE4","title":"Study Comparing Prandial Insulin Aspart vs. Technosphere Insulin in Patients With Type 1 Diabetes on Multiple Daily Injections: Investigator-Initiated A Real-life Pilot Study-STAT Study","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2017-09-30","conditions":"Diabetes Mellitus, Type 1","enrollment":60},{"nctId":"NCT02898506","phase":"PHASE2","title":"Incretin-based Therapy in Late Preclinical Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Oulu","startDate":"2016-03","conditions":"Type 1 Diabetes","enrollment":13},{"nctId":"NCT03740919","phase":"PHASE3","title":"A Study Comparing LY900014 to Insulin Lispro (Humalog) in Children and Adolescents With Type 1 Diabetes","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2019-04-07","conditions":"Type 1 Diabetes Mellitus","enrollment":751},{"nctId":"NCT04213300","phase":"","title":"Low Carbohydrate Diet, Glycaemic Control and Quality of Life in Australian Adults With Type 1 Diabetes","status":"COMPLETED","sponsor":"Gold Coast Hospital and Health Service","startDate":"2021-01-15","conditions":"Type 1 Diabetes Mellitus","enrollment":23},{"nctId":"NCT04189510","phase":"NA","title":"Use of Closed Loop Insulin Delivery for Glucose Control in Patients With Insulin Dependent Diabetes Mellitus After Kidney Transplantation","status":"WITHDRAWN","sponsor":"University of Virginia","startDate":"2021-04-01","conditions":"Type 1 Diabetes, Insulin-requiring Type 2 Diabetes Mellitus, End Stage Renal Disease (ESRD)","enrollment":""},{"nctId":"NCT04509362","phase":"","title":"An 8-Day Initiation of Advanced Hybrid Closed Loop System In Children and Adolescents","status":"COMPLETED","sponsor":"Sidra Medicine","startDate":"2020-10-01","conditions":"Type 1 Diabetes","enrollment":34},{"nctId":"NCT04667182","phase":"","title":"A Study of Glucose Control in Participants With Type 1 and Type 2 Diabetes","status":"WITHDRAWN","sponsor":"Eli Lilly and Company","startDate":"2021-01-25","conditions":"Type 1 Diabetes, Type 2 Diabetes","enrollment":""},{"nctId":"NCT03987191","phase":"PHASE4","title":"Insulin Pump to Multiple Daily Injection Transition Clinical Trial","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2020-01-10","conditions":"Type 1 Diabetes","enrollment":38},{"nctId":"NCT03445065","phase":"NA","title":"A French Study to Evaluate the Usefulness of an Implantable Continuous Glucose Monitoring (CGM) Sensor to Improve Glycemic Control in Participants With Diabetes Mellitus","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2018-02-28","conditions":"Diabetes Mellitus","enrollment":239},{"nctId":"NCT03478969","phase":"NA","title":"Participant-Reported Outcomes With the Accu-Chek® Solo Micropump System","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2018-05-17","conditions":"Diabetes Mellitus, Type 1","enrollment":181},{"nctId":"NCT04043260","phase":"NA","title":"DreaMed Advisor Pro System in Subjects With Type 1 Diabetes Treated With MDI Therapy","status":"COMPLETED","sponsor":"DreaMed Diabetes","startDate":"2019-11-27","conditions":"Insulin-dependent Diabetes Mellitus, Diabetes Mellitus, Type 1","enrollment":35},{"nctId":"NCT02527265","phase":"PHASE2","title":"Afrezza Safety and Pharmacokinetics Study in Pediatric Patients","status":"COMPLETED","sponsor":"Mannkind Corporation","startDate":"2017-09-28","conditions":"Type 1 Diabetes Mellitus","enrollment":30},{"nctId":"NCT03766854","phase":"PHASE1","title":"A Research Study of How Different Amounts of a New Medicine NNC0148-0287 C (Insulin 287) Works on the Blood Sugar of People Who Are Japanese With Type 1 Diabetes When Given Once a Week","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2018-12-07","conditions":"Diabetes Mellitus, Type 1","enrollment":24},{"nctId":"NCT04756011","phase":"","title":"Health-related Quality of Life and Psychosocial Aspects of Diabetes Technology (Insulin Pumps)","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2020-03-15","conditions":"T1DM, Health Related Quality of Life, Insulin Pump","enrollment":60},{"nctId":"NCT04145804","phase":"NA","title":"Hybrid Closed Loop System for Patients on Multiple Daily Insulin Injections","status":"UNKNOWN","sponsor":"Hamad Medical Corporation","startDate":"2020-01-01","conditions":"Type 1 Diabetes","enrollment":40},{"nctId":"NCT01616784","phase":"PHASE3","title":"The REPOSE (Relative Effectiveness of Pumps Over MDI and Structured Education) Trial","status":"COMPLETED","sponsor":"Sheffield Teaching Hospitals NHS Foundation Trust","startDate":"2011-11","conditions":"Type 1 Diabetes","enrollment":267},{"nctId":"NCT03687827","phase":"PHASE4","title":"A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO Study","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2018-10-02","conditions":"Diabetes Mellitus, Type 2","enrollment":498}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":116,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Basal bolus injections of insulin"],"phase":"marketed","status":"active","brandName":"Multiple Daily Injections of Insulin","genericName":"Multiple Daily Injections of Insulin","companyName":"DreaMed Diabetes","companyId":"dreamed-diabetes","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Multiple daily insulin injections replace or supplement the body's own insulin production to regulate blood glucose levels. Used for Type 1 diabetes mellitus, Type 2 diabetes mellitus (when oral agents are insufficient).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}